Universitat Internacional de Catalunya
Coordinator:
Dra. HURTADO BARROSO, Sara - shurtado@uic.es
Questions will mainly be addressed during class sessions. For questions outside class hours, please contact the course coordinator by email.
Dr. Sara Hurtado Barroso (shurtado@uic.es)
Dr. Cristina Moreta Moraleda (cmoreta@uic.es)
Vega Espinosa Cale (vega.esca@uic.es)
This course provides a comprehensive overview of clinical trials in biomedical research, covering their types, regulatory framework, and key ethical considerations. It examines the methodological principles underlying trial design and implementation, as well as their pivotal role in generating scientific evidence for the prevention, diagnosis, and treatment of major health conditions. Additionally, the course explores the translational impact of clinical trials and their contribution to therapeutic innovation and the advancement of clinical practice.
It is recommended to have basic knowledge of cell and molecular biology, cancer biology, nutrition, pharmacology, and the pathological basis of human diseases.
The objectives of the course are:
By the end of the course, students should be able to:
Recognise the different types of clinical trials and the context in which they take place.
Identify the stages of preclinical and clinical research in clinical trials.
Analyse the potential of translational research in clinical practice.
Associate therapeutic advances with different areas of health.
Design and manage a clinical trial within the field of biomedical sciences.
Block I. General Aspects of Clinical Trials
Topic 1. Course presentation. Definition and context of clinical trials
Topic 2. Types of clinical trials
Topic 3. Clinical trial design. Statistics. Pharmacovigilance
Block II. Clinical Trial Management
Topic 4. Documentation and legislation in clinical trials. Ethics and quality. Good Clinical Practice
CBL 1. Clinical trial protocol
CBL 2. Case Report Form
Simulation practice: recruitment and follow-up of a clinical trial
Block III. Clinical Trial Applications
Topic 5. Clinical trials in cancer
Topic 6. Clinical trials in neurological and autoimmune diseases
Seminars on clinical trials
CBL 3. Clinical trial session in cancer
CBL 4. Clinical trial session in mental and neurological diseases
CBL 5. Clinical trial session in autoimmune diseases
CBL 6. Clinical trial session in nutrition and metabolic diseases
Lectures – 16 hours: presentation of a theoretical topic by the teaching staff. During the course, a series of seminars will be given by external experts on the topics covered in the lectures.
Clinical cases or case method (CM) – 12 hours: presentation of a real or hypothetical situation. Students work on the proposed questions in small groups or through active interaction with the teacher, and the answers are discussed. The teaching staff actively participates and, if necessary, provides new knowledge.
Practical classes – 2 hours: simulation-based practical session carried out at the Comprehensive Centre for Advanced Simulation (CISA), focusing on the concepts covered in the theoretical lectures under the supervision of the teaching staff.
1. Students taking the course for the first time:
Students who contribute valuable ideas or ask relevant questions that enhance the quality of the classes may obtain an additional 5% excellence mark. This mark will only be awarded to students who actively participate throughout the course.
2. Students resitting the course (second examination period): the marks obtained for the case-based learning activities, practical sessions and midterm examination will be retained.
3. Students taking the course for the third or subsequent examination periods: the marks obtained for the case-based learning activities and practical sessions will be retained. However, students may choose to attend these learning activities again in order to obtain a new mark.
General assessment criteria: